Showing results (21-30 of 2,161) with videos related to
Sort By:
Pageof 217
The Journal of Biological Chemistry|October 15, 1992
Transforming growth factor beta 1 stimulates the production of basic fibroblast growth factor binding proteoglycans in Balb/c3T3 cellsM A Nugent, E R EdelmanBiophysical Journal|March 1, 1996
Tissue average binding and equilibrium distribution: an example with heparin in arterial tissuesM A Lovich, E R EdelmanJournal of Pharmaceutical Sciences|December 1, 1996
Quantification of insulin release from implantable polymer-based delivery systems and augmentation of therapeutic effect with simultaneous release of somatostatinE R Edelman, L Brown, R LangerCirculation Research|March 6, 1999
Endothelial implants inhibit intimal hyperplasia after porcine angioplastyH M Nugent, C Rogers, E R EdelmanJournal of Biomedical Materials Research|November 24, 1999
Mechanisms of heparin transport through expanded poly(tetrafluoroethylene) vascular graftsI Noh, M A Lovich, E R EdelmanThe Journal of Biological Chemistry|November 22, 1996
Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactionsI D Dinbergs, L Brown, E R EdelmanThe Journal of Clinical Investigation|June 1, 1994
Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury modelM Simons, E R Edelman, R D RosenbergMedical & Biological Engineering & Computing|March 21, 2000
Measuring arterial strain induced by endovascular stentsJ C Squire, C Rogers, E R EdelmanCirculation|February 4, 1997
Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickeningM G Sirois, M Simons, E R EdelmanCirculation|September 1, 1993
Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administrationC Rogers, M J Karnovsky, E R EdelmanPageof 217